Related Experiment Video
Updated: Aug 8, 2026
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Multiple myeloma and immune thrombocytopenia
V Gupta1, U M Hegde, R Parameswaran
1Ealing Hospital, Southall, Middlesex, UK.
Immune thrombocytopenia (ITP) is rarely seen in multiple myeloma patients. Early ITP symptoms may mask underlying myeloma, requiring careful diagnosis and management for better outcomes.
Area of Science:
- Hematology
- Oncology
Background:
- Immune thrombocytopenia (ITP) is common in lymphoproliferative disorders.
- ITP is infrequently reported in multiple myeloma (MM).
Observation:
- Three cases presented with ITP clinical manifestations.
- Myeloma was diagnosed subsequently in these patients.
- Standard ITP treatments yielded transient or partial platelet count responses.
Findings:
- ITP can be an initial presentation of multiple myeloma.
- Myeloma-associated ITP may show limited response to conventional therapies.
Implications:
- Recognizing immune-mediated thrombocytopenia in myeloma is crucial.
- Understanding this combination aids in diagnosis and treatment strategies.
- Further research is needed on managing ITP in myeloma patients.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
